Phase I/II dose-escalation study of 225Ac-J591 in progressive mCRPC

Scott T. Tagawa, MD, MS, Weill Cornell Medical College, New York Presbyterian Hospital, NY, discusses the results of a dose-escalation…

Read the full article here

Related Articles